CA1319107C - Compositions empechant le transport de glucose - Google Patents

Compositions empechant le transport de glucose

Info

Publication number
CA1319107C
CA1319107C CA000568512A CA568512A CA1319107C CA 1319107 C CA1319107 C CA 1319107C CA 000568512 A CA000568512 A CA 000568512A CA 568512 A CA568512 A CA 568512A CA 1319107 C CA1319107 C CA 1319107C
Authority
CA
Canada
Prior art keywords
agent
tumor
glucose
cell
tissue surrounding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000568512A
Other languages
English (en)
Inventor
Rudolf Edgard Falk
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FALK RUDOLF EDGARD
Original Assignee
Rudolf Edgard Falk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rudolf Edgard Falk filed Critical Rudolf Edgard Falk
Priority to CA000568512A priority Critical patent/CA1319107C/fr
Application granted granted Critical
Publication of CA1319107C publication Critical patent/CA1319107C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
CA000568512A 1988-06-02 1988-06-02 Compositions empechant le transport de glucose Expired - Fee Related CA1319107C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA000568512A CA1319107C (fr) 1988-06-02 1988-06-02 Compositions empechant le transport de glucose

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA000568512A CA1319107C (fr) 1988-06-02 1988-06-02 Compositions empechant le transport de glucose

Publications (1)

Publication Number Publication Date
CA1319107C true CA1319107C (fr) 1993-06-15

Family

ID=4138131

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000568512A Expired - Fee Related CA1319107C (fr) 1988-06-02 1988-06-02 Compositions empechant le transport de glucose

Country Status (1)

Country Link
CA (1) CA1319107C (fr)

Similar Documents

Publication Publication Date Title
US6448287B1 (en) Treatment of cancer using lipoic acid in combination with ascorbic acid
US5225404A (en) Methods of treating colon tumors with tumor-inhibiting camptothecin compounds
RU2162327C2 (ru) Лечение рака и профилактика метастазирования
Reitemeier et al. Combination chemotherapy in gastrointestinal cancer
EP2063881B1 (fr) Composition et méthode pour administrer efficacement et sans danger un halopyruvate pour traiter un cancer
JPS6388128A (ja) 腫瘍細胞転移抑制剤
Kajanti et al. Epirubicin-sequential methotrexate-5-fluorouracil-leucovorin treatment in advanced cancer of the extrahepatic biliary system: a phase II study
EP3432929A1 (fr) Utilisation de caroténoïdes trans bipolaires avec une chimiothérapie et une radiothérapie en vue du traitement d'un cancer
WO2001074368A1 (fr) Therapies combinees induisant un effet de deterioration vasculaire
Tewes et al. Capecitabine and irinotecan as first-line chemotherapy in patients with metastatic colorectal cancer: results of an extended phase I study
Ariel Therapeutic effects of hydroxyurea. Experience with 118 patients with inoperable solid tumors
CA2286557A1 (fr) Phorbol esters utilises en tant qu'agents anti-neoplasiques
US4384001A (en) Treatment of tumors with thiazolidine-4-carboxylic acid
CA1319107C (fr) Compositions empechant le transport de glucose
JP2974740B2 (ja) 肝臓、血液および血漿のアデノシン５’‐三リン酸濃度を増加させるための薬剤
Casper et al. Phase II trial of fazarabine (arabinofuranosyl-5-azacytidine) in patients with advanced pancreatic adenocarcinoma
US7879814B2 (en) Methods and therapeutic compositions in the treatment of advanced cancer
Collier et al. Doxorubicin hydrochloride, cyclophosphamide, and 5-fluorouracil combination in advanced prostate and transitional cell carcinoma
US20030139373A1 (en) Method for cancer therapy
Ramirez et al. Pharmacology and antitumour effects of intraportal pirarubicin on experimental liver metastases
EA004570B1 (ru) Применение производного антрациклина для лечения опухоли печени
Kakizaki et al. Preoperative one-shot intra-arterial infusion chemotherapy for bladder cancer
Stathopoulos et al. Effect of adriamycin, 5-Fluorouracil and mitomycin-C combination chemotherapy in advanced colorectal cancer
Horsman et al. The ability of nicotinamide to inhibit the growth of a C3H mouse mammary carcinoma
Vaughn et al. Combination chemotherapy in advanced gastrointestinal malignancy

Legal Events

Date Code Title Description
MKLA Lapsed